Is there a public PoC exploit available for CVE-2026-10246?

Yes, a public proof-of-concept exploit is available for CVE-2026-10246. Prioritise patching immediately. EPSS: 0.0%.

Pharmacy Sales and Inventory System CVE-2026-10246

Q: What is the CVSS score of CVE-2026-10246?

CVE-2026-10246 has a CVSS 4.0 base score of 2.0 (Low). CVSS vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X. EPSS exploitation probability: 0.0%.

EUVD-2026-33620 LOW

Cross-site Scripting (XSS) (CWE-79)

2026-06-01 VulDB

GHSA-cvf2-cgfw-jqr4

XSS Pharmacy Sales And Inventory System Sourcecodester

2.0

CVSS 4.0 · Vendor: VulDB

Severity by source

Vendor (VulDB) PRIMARY

2.0 LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Primary rating from Vendor (VulDB) · only source for this CVE.

CVSS VectorVendor: VulDB

Attack Vector

Network

Attack Complexity

Low

Privileges Required

Low

User Interaction

Scope

Lifecycle Timeline

Analysis Generated

Jun 01, 2026 - 11:22 vuln.today

CVSS changed

Jun 01, 2026 - 11:22 NVD

3.5 (LOW) 2.0 (LOW)

DescriptionCVE.org

A vulnerability has been found in SourceCodester Pharmacy Sales and Inventory System 1.0. This affects the function create_medicine_presentation of the file /ShowForm/create_medicine_presentation/main. The manipulation of the argument medicine_presentation leads to cross site scripting. The attack may be initiated remotely. The exploit has been disclosed to the public and may be used.

AnalysisAI

Stored or reflected cross-site scripting in SourceCodester Pharmacy Sales and Inventory System 1.0 allows a low-privileged authenticated remote attacker to inject malicious JavaScript via the medicine_presentation argument in the create_medicine_presentation function at /ShowForm/create_medicine_presentation/main. Exploitation requires a victim user to interact with the affected page, limiting blast radius but still enabling session hijacking, credential theft, or UI redirection against authenticated users. Publicly available exploit code exists per a GitHub issue disclosure; no CISA KEV listing is present.

Technical ContextAI

The vulnerability is classified under CWE-79 (Improper Neutralization of Input During Web Page Generation), indicating that user-supplied input in the medicine_presentation parameter is not adequately sanitized or encoded before being rendered in the HTML response. The affected product, identified via CPE cpe:2.3:a:sourcecodester:pharmacy_sales_and_inventory_system:*:*:*:*:*:*:*:*, is a PHP-based web application distributed by SourceCodester - a platform known for publishing open-source academic/demo projects frequently targeted due to minimal security hardening. The vulnerable endpoint /ShowForm/create_medicine_presentation/main processes medicine presentation form submissions, and the lack of output encoding allows injected script tags or event handlers to execute in a victim's browser context.

RemediationAI

No vendor-released patch has been identified at the time of analysis - the SourceCodester project page (https://www.sourcecodester.com/) does not publish a security advisory or patched release. The upstream fix, if any, is not independently confirmed from the available references. As a primary compensating control, operators should implement strict server-side input validation and context-aware output encoding (HTML entity encoding) on all user-supplied values processed by the create_medicine_presentation function, particularly the medicine_presentation parameter. Deploying a Web Application Firewall (WAF) with XSS filtering rules can reduce exploitation likelihood but introduces a risk of bypass and should not be treated as a complete fix. Restricting access to the /ShowForm/create_medicine_presentation/main endpoint to trusted internal networks or specific authenticated roles limits attack surface, with the trade-off of reduced functionality for legitimate remote users. Organizations running this application in production should evaluate whether the codebase meets their security baseline given its origins as a demo project.